Sterilization of health care products. General requirements for characterization of a sterilizing agent and the development, validation and routine control of a sterilization process for medical devices (ISO 14937:2009)
Tuote ladattavissa hetiToimitusaika on noin 1 - 2 työpäivääToimitusaika on 3 - 5 työpäivää.
ISO 14937:2009 specifies general requirements for the characterization of a sterilizing agent and for the development, validation and routine monitoring and control of a sterilization process for medical devices. It applies to sterilization processes in which microorganisms are inactivated by physical and/or chemical means and is intended to be applied by process developers, manufacturers of sterilization equipment, manufacturers of medical devices to be sterilized, and organizations responsible for sterilizing medical devices. ISO 14937:2009 specifies the elements of a Quality Management System which are necessary to assure the appropriate characterization of the sterilizing agent, development, validation and routine monitoring and control of a sterilization process.
Tämän julkaisun valmistelusta Suomessa vastaa Palvelualojen työnantajat PALTA ry, puh. 040 579 4393.
Sisällysluettelo
Foreword
Introduction
1 Scope
1.1 Inclusions
1.2 Exclusions
2 Normative references
3 Terms and definitions
4 Quality management system elements
4.1 Documentation
4.2 Management responsibility
4.3 Product realization
4.4 Measurement, analysis and improvement — Control of non-conforming product
5 Sterilizing agent characterization
5.1 General
5.2 Sterilizing agent
5.3 Microbicidal effectiveness
5.4 Effects on materials
5.5 Safety and the environment
6 Process and equipment characterization
6.1 General
6.2 Process characterization
6.3 Equipment characterization
7 Product definition
8 Process definition
9 Validation
9.1 General
9.2 Installation qualification
9.3 Operational qualification
9.4 Performance qualification
9.5 Review and approval of validation
10 Routine monitoring and control
11 Product release from sterilization
12 Maintaining process effectiveness
12.1 General
12.2 Recalibration
12.3 Maintenance of equipment
12.4 Requalification
12.5 Assessment of change
Annex A Factors to be considered in selection of microorganisms for demonstrating microbicidal effectiveness (normative)
Annex B Approach 1 — Process definition based on inactivation of the microbial population in its natural state (normative)
Annex C Approach 2 — Process definition based on inactivation of reference microorganisms and knowledge of bioburden (normative)
Annex D Approach 3 — Conservative process definition based on inactivation of reference microorganisms (normative)
Annex E Guidance on application of this International Standard (informative)
IEC 61010-2-040:2005
ISO 10012:2003 Measurement management systems -- Requirements for measurement processes and measuring equipment
ISO 10993-17:2002 Biological evaluation of medical devices -- Part 17: Establishment of allowable limits for leachable substances
IEC 61010-2-040:2005
ISO 10012:2003 Measurement management systems -- Requirements for measurement processes and measuring equipment
ISO 10993-17:2002 Biological evaluation of medical devices -- Part 17: Establishment of allowable limits for leachable substances
ISO 10993-1:2009 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process
ISO 11138-1:2006 Sterilization of health care products -- Biological indicators -- Part 1: General requirements
ISO 11140-1:2005 Sterilization of health care products -- Chemical indicators -- Part 1: General requirements
ISO 11737-1:2006 Sterilization of medical devices -- Microbiological methods -- Part 1: Determination of a population of microorganisms on products
ISO 11737-2:1998 Sterilization of medical devices -- Microbiological methods -- Part 2: Tests of sterility performed in the validation of a sterilization process
ISO 13485:2003 Medical devices -- Quality management systems -- Requirements for regulatory purposes